German Society of Ophthalmology

Article

The DOG (Deutsche Ophthalmologische Gesellschaft) was founded in 1857 when a group of like-minded ophthalmologists, brought together by Albrecht von Greafe, met in Heidelberg to discuss the latest developments in their profession. This first meeting was organized to take place a few days before the international ophthalmology conference in Brussels with the idea that they would then travel on together to attend. In all, twelve people arrived in Heidleberg, where discussion topics ranged from the use of compression bandages to glaucoma treatment. It was considered such a success that they agreed to meet again the following year.

The DOG (Deutsche Ophthalmologische Gesellschaft) was founded in 1857 when a group of like-minded ophthalmologists, brought together by Albrecht von Greafe, met in Heidelberg to discuss the latest developments in their profession. This first meeting was organized to take place a few days before the international ophthalmology conference in Brussels with the idea that they would then travel on together to attend. In all, twelve people arrived in Heidleberg, where discussion topics ranged from the use of compression bandages to glaucoma treatment. It was considered such a success that they agreed to meet again the following year.

Titled "Ophthalmology in the Aging Society", the meeting, to be held in Berlin, Germany from September 21-24, will be focusing on the challenges facing ophthalmologists in the current climate. Topics for discussion will include the screening of age-related diseases, age-adapted therapy, the ageing of the visual system versus disease and the epidemiology of age-related diseases. Furthermore, the meeting will also include courses on how to write a successful grant proposal, preparing scientific papers and preparing a successful scientific presentation. Career planning and advice will also be available for young scientists attending the meeting.

"I have made it my goal to mould the society into one that has a stronger scientific appearance and identity," says society President Professor Norbert Pfeiffer.

To learn more about DOG, please go to http://www.dog.org/

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.